α-Glucosidase-IN-23

Research use only, not for human use.

α-Glucosidase-IN-23 is an orally active inhibitor of α-glucosidase that can decrease blood glucose levels by inhibiting α-glucosidase (IC50 = 4.48 μM).

α-Glucosidase-IN-23 is an orally active α-Glucosidase inhibitor. α-Glucosidase-IN-23 decreases blood glucose by a-glucosidase inhibition with an IC50 value of 4.48 μM. α-Glucosidase-IN-23 can be used for the research of diabetes.

Cell Proliferation AssayCell Line:INS-1 Cells Concentration:1 μM Incubation Time:Result:Stimulated the growth of INS-1 cells in a dose-codependent approach.Apoptosis AnalysisCell Line:INS-1 Cells Concentration:1 μM Incubation Time:Result:Restored the viability of INS-1 cells by about five times from apoptosis and eight times from necrosis.

——

——

Others

Other Targets

Glucosidase

——

——

161187-57-1

373.4

C20H23NO6

>98% (HPLC)

——

C(OCC)(=O)C=1C(C(C(OCC)=O)=C(C)NC1C)C2=C3C(=CC=C2)OCO3

——

(-20℃)

With Ice Pack

≥ 2 years